Standout Papers
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19 (2022)
- The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials (2023)
- Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults (2024)
Immediate Impact
1 by Nobel laureates 52 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
2025 Standout
Works of Brandon Essink being referenced
The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials
2023 Standout
A Bivalent Omicron-Containing Booster Vaccine against Covid-19
2022 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brandon Essink | 590 | 375 | 152 | 207 | 35 | 997 | |
| Shipo Wu | 684 | 254 | 186 | 328 | 38 | 1.2k | |
| Rituparna Das | 693 | 680 | 174 | 165 | 62 | 1.4k | |
| Amin Addetia | 990 | 169 | 148 | 322 | 34 | 1.3k | |
| Harry M. Meyer | 413 | 910 | 178 | 96 | 39 | 1.3k | |
| Preeyaporn Vichaiwattana | 505 | 451 | 68 | 91 | 64 | 926 | |
| Edith Jasny | 509 | 188 | 408 | 379 | 19 | 1.0k | |
| Branda Hu | 546 | 454 | 140 | 163 | 33 | 1.1k | |
| Ramona Trebbien | 446 | 755 | 94 | 116 | 64 | 1.1k | |
| Vanessa Escuret | 523 | 761 | 93 | 192 | 54 | 1.2k | |
| Harvey Liebhaber | 265 | 568 | 100 | 132 | 28 | 979 |
All Works
Login with ORCID to disown or claim papers
Loading papers...